Cogent Biosciences, Inc.
COGT
$11.40
-$0.02-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.84% | -0.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.63% | -2.23% | |||
| Operating Income | -1.63% | 2.23% | |||
| Income Before Tax | -5.98% | 3.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.98% | 3.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.98% | 3.83% | |||
| EBIT | -1.63% | 2.23% | |||
| EBITDA | -1.62% | 2.25% | |||
| EPS Basic | -4.17% | 4.94% | |||
| Normalized Basic EPS | -12.47% | 11.95% | |||
| EPS Diluted | -4.17% | 4.94% | |||
| Normalized Diluted EPS | -12.47% | 11.95% | |||
| Average Basic Shares Outstanding | 1.73% | 1.17% | |||
| Average Diluted Shares Outstanding | 1.73% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||